Indegene Limited (NSE:INDGN)
India · Delayed Price · Currency is INR 511.15
-7.30 (-1.41%)
Jun 3, 2026, 1:29 PM IST
Indegene Revenue
In the fiscal year ending March 31, 2026, Indegene had annual revenue of 35.11B INR with 23.64% growth. Indegene had revenue of 10.03B in the quarter ending March 31, 2026, with 32.80% growth.
Revenue
35.11B
Revenue Growth
+23.64%
P/S Ratio
3.54
Revenue / Employee
8.44M
Employees
4,158
Market Cap
124.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 35.11B | 6.71B | 23.64% |
| Mar 31, 2025 | 28.39B | 2.50B | 9.64% |
| Mar 31, 2024 | 25.90B | 2.84B | 12.29% |
| Mar 31, 2023 | 23.06B | 6.41B | 38.54% |
| Mar 31, 2022 | 16.65B | 6.84B | 69.76% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 584.62B |
| Cipla | 277.12B |
| Apollo Hospitals Enterprise | 252.29B |
| Divi's Laboratories | 105.60B |
| Marksans Pharma | 29.51B |
| Alivus Life Sciences | 25.52B |
| Rainbow Children's Medicare | 17.03B |
| Park Medi World | 16.79B |
Indegene News
- 6 days ago - Indegene Slides: Investor presentation - Filings
- 4 weeks ago - Indegene Transcript: Q4 25/26 - Transcripts
- 4 weeks ago - Indegene Quarterly report: Q4 2026 - Filings
- 4 weeks ago - Indegene Slides: Q4 2026 - Filings
- 4 months ago - Indegene Transcript: Q3 25/26 - Transcripts
- 4 months ago - Indegene Quarterly report: Q3 2026 - Filings
- 4 months ago - Indegene Slides: Q3 2026 - Filings
- 7 months ago - Indegene Transcript: Q2 25/26 - Transcripts